1. Li, Yajun, Cui, Kaisa, Zhang, Qiang, Prochownik, Edward V, Li, Youjun. 2021. FBXL6 degrades phosphorylated p53 to promote tumor growth. In Cell death and differentiation, 28, 2112-2125. doi:10.1038/s41418-021-00739-6. https://pubmed.ncbi.nlm.nih.gov/33568778/
2. Tao, Dianxin, Lou, Shenghan, Huang, Wei, Meng, Fanling, Lou, Ge. 2024. Clinical and prognostic significance of FBXL6 expression in ovarian cancer. In Gene, 933, 148978. doi:10.1016/j.gene.2024.148978. https://pubmed.ncbi.nlm.nih.gov/39368786/
3. Shi, Weidong, Feng, Lanyun, Dong, Shu, Chen, Zhen, Meng, Zhiqiang. 2020. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1. In Cell communication and signaling : CCS, 18, 100. doi:10.1186/s12964-020-00604-y. https://pubmed.ncbi.nlm.nih.gov/32576198/
4. Yu, Yongchun, Yao, Wenhao, Wang, Tengda, Yu, Yipeng, Zhang, Cheng. 2022. FBXL6 depletion restrains clear cell renal cell carcinoma progression. In Translational oncology, 26, 101550. doi:10.1016/j.tranon.2022.101550. https://pubmed.ncbi.nlm.nih.gov/36183674/
5. Lin, Qingyuan, Zhu, Jinchao, Zhu, Weiyao, Jia, Shouqiang, Nie, Shengdong. 2024. Prognostic value and drug sensitivity of F‑box and leucine‑rich repeat protein 6 in glioma. In Oncology letters, 28, 320. doi:10.3892/ol.2024.14453. https://pubmed.ncbi.nlm.nih.gov/38807668/
6. Ni, Lin, Li, He, Cui, Yanqi, Zhao, Hu, Wang, Bing. 2025. Construction of a circadian rhythm-related gene signature for predicting the prognosis and immune infiltration of breast cancer. In Frontiers in molecular biosciences, 12, 1540672. doi:10.3389/fmolb.2025.1540672. https://pubmed.ncbi.nlm.nih.gov/39981438/
7. Hosseinzadeh, Sevda, Rafat, Seyed Abbas, Javanmard, Arash, Fang, Lingzhao. 2024. Identification of candidate genes associated with milk production and mastitis based on transcriptome-wide association study. In Animal genetics, 55, 430-439. doi:10.1111/age.13422. https://pubmed.ncbi.nlm.nih.gov/38594914/
智鼠故事 
